Schweizer M - Search Results

1

[Therapeutic approaches using genetically modified cells].

Anliker B, Renner M, Schweizer M. Anliker B, et al. Among authors: schweizer m. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Nov;58(11-12):1274-80. doi: 10.1007/s00103-015-2245-z. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015. PMID: 26349563 Review. German.

2

Tropism, intracerebral distribution, and transduction efficiency of HIV- and SIV-based lentiviral vectors after injection into the mouse brain: a qualitative and quantitative in vivo study.

Hlavatý J, Tonar Z, Renner M, Panitz S, Petznek H, Schweizer M, Schüle S, Kloke BP, Moldzio R, Witter K. Hlavatý J, et al. Among authors: schweizer m. Histochem Cell Biol. 2017 Sep;148(3):313-329. doi: 10.1007/s00418-017-1569-1. Epub 2017 Apr 10. Histochem Cell Biol. 2017. PMID: 28397143 Free PMC article.

3

Large-scale production means for the manufacturing of lentiviral vectors.

Schweizer M, Merten OW. Schweizer M, et al. Curr Gene Ther. 2010 Dec;10(6):474-86. doi: 10.2174/156652310793797748. Curr Gene Ther. 2010. PMID: 21054245 Review.

4

Functional HIV-2- and SIVsmmPBj- derived lentiviral vectors generated by a novel polymerase chain reaction-based approach.

Kloke BP, Schüle S, Mühlebach MD, Wolfrum N, Cichutek K, Schweizer M. Kloke BP, et al. Among authors: schweizer m. J Gene Med. 2010 May;12(5):446-52. doi: 10.1002/jgm.1454. J Gene Med. 2010. PMID: 20440755

5

Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model.

Schüle S, Steidl S, Panitz S, Coulibaly C, Kalinke U, Cichutek K, Schweizer M. Schüle S, et al. Among authors: schweizer m. Virology. 2006 Jul 20;351(1):237-47. doi: 10.1016/j.virol.2006.03.034. Epub 2006 May 2. Virology. 2006. PMID: 16650881 Free article.

6

Stable transduction of primary human monocytes by simian lentiviral vector PBj.

Mühlebach MD, Wolfrum N, Schüle S, Tschulena U, Sanzenbacher R, Flory E, Cichutek K, Schweizer M. Mühlebach MD, et al. Among authors: schweizer m. Mol Ther. 2005 Dec;12(6):1206-16. doi: 10.1016/j.ymthe.2005.06.483. Epub 2005 Sep 16. Mol Ther. 2005. PMID: 16150648 Free article.

7

Genetic engineering of onco/lentivirus hybrids results in formation of infectious but not of replication-competent viruses.

Steidl S, Schüle S, Mühlebach MD, Stitz J, Boller K, Cichutek K, Schweizer M. Steidl S, et al. Among authors: schweizer m. J Gen Virol. 2004 Mar;85(Pt 3):665-678. doi: 10.1099/vir.0.19479-0. J Gen Virol. 2004. PMID: 14993652

8

Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes.

Mühlebach MD, Schmitt I, Steidl S, Stitz J, Schweizer M, Blankenstein T, Cichutek K, Uckert W. Mühlebach MD, et al. Among authors: schweizer m. J Mol Med (Berl). 2003 Dec;81(12):801-10. doi: 10.1007/s00109-003-0491-2. Epub 2003 Oct 24. J Mol Med (Berl). 2003. PMID: 14576928

9

Coreceptor Switch of [MLV(SIVagm)] pseudotype vectors by V3-loop exchange.

Steidl S, Stitz J, Schmitt I, König R, Flory E, Schweizer M, Cichutek K. Steidl S, et al. Among authors: schweizer m. Virology. 2002 Sep 1;300(2):205-16. doi: 10.1006/viro.2001.1565. Virology. 2002. PMID: 12350351 Free article.

10

Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj.

Schüle S, Kloke BP, Kaiser JK, Heidmeier S, Panitz S, Wolfrum N, Cichutek K, Schweizer M. Schüle S, et al. Among authors: schweizer m. PLoS One. 2009 Sep 21;4(9):e7098. doi: 10.1371/journal.pone.0007098. PLoS One. 2009. PMID: 19768115 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

760 results

Search Page